肾浓缩能力评估

Assessment of renal concentrating ability.

作者信息

Curtis J R, Donovan B A

出版信息

Br Med J. 1979 Feb 3;1(6159):304-5. doi: 10.1136/bmj.1.6159.304.

DOI:10.1136/bmj.1.6159.304

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1597680/

Abstract

Maximum urine osmolality was measured during a 24-hour control period in normal ambulant and working subjects and hospital inpatients and compared with that achieved after intramuscular injection of 4 microgram desamino-cys-1-8-D-arginine vasopressin (DDAVP). Most of the normal subjects passed maximally concentrated urine at some time during the control period. The results suggest that in less active subjects or hospital inpatients the DDAVP test is a suitable method of assessing renal concentrating ability.

摘要

在正常可走动及工作的受试者以及住院患者的24小时对照期内测量最大尿渗透压，并将其与肌肉注射4微克去氨基-半胱氨酸-1-8-D-精氨酸加压素（DDAVP）后所达到的最大尿渗透压进行比较。大多数正常受试者在对照期的某个时间排出了最大浓缩尿。结果表明，对于活动较少的受试者或住院患者，DDAVP试验是评估肾脏浓缩能力的一种合适方法。

相似文献

1

Assessment of renal concentrating ability.肾浓缩能力评估

Br Med J. 1979 Feb 3;1(6159):304-5. doi: 10.1136/bmj.1.6159.304.

2

Evaluation of renal concentrating ability with DDAVP and pitressin.用去氨加压素和垂体后叶素评估肾脏浓缩能力。

Scand J Urol Nephrol. 1983;17(1):69-71. doi: 10.3109/00365598309179785.

3

Desamino arginine vasopressin (DDAVP) as a diagnostic agent.去氨基精氨酸血管加压素（DDAVP）作为一种诊断剂。

N Z Med J. 1977 Nov 23;86(600):472-3.

4

Assessment of renal concentrating ability in lithium-treated patients. Comparison of long-term dehydration with administration of a vasopressin analogue.锂治疗患者肾脏浓缩能力的评估。长期脱水与给予血管加压素类似物的比较。

Acta Psychiatr Scand. 1980 Feb;61(2):152-6. doi: 10.1111/j.1600-0447.1980.tb00574.x.

5

DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of lithium-induced polyuria in the rat.去氨加压素（1-去氨基-8-D-精氨酸加压素）对大鼠锂诱导性多尿的治疗作用

Scand J Clin Lab Invest. 1980 Apr;40(2):151-7. doi: 10.3109/00365518009093018.

6

DDAVP test for assessment of renal concentrating capacity in infants and children.用于评估婴幼儿和儿童肾脏浓缩功能的去氨加压素试验。

Nephron. 1981;29(3-4):151-4. doi: 10.1159/000182339.

7

[Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in a simple test of renal concentrating ability].

Z Gesamte Inn Med. 1984 Jun 1;39(11):265-8.

8

1-desamino-8-D-arginine vasopressin (DDAVP) concentration test.

Am J Med Sci. 1978 Jan-Feb;275(1):43-52.

9

Intranasal DDAVP-test in the study of renal concentrating capacity in children with recurrent urinary tract infections.鼻内去氨加压素试验在复发性尿路感染儿童肾脏浓缩功能研究中的应用

Eur J Pediatr. 1979 Mar 1;130(3):149-54. doi: 10.1007/BF00455260.

10

Subcutaneous and intranasal administration of 1-deamino-8-d-arginine vasopressin in the assessment of renal concentration capacity.皮下及鼻内给予1-去氨基-8-D-精氨酸加压素用于评估肾脏浓缩功能。

Nephron. 1987;45(1):27-30. doi: 10.1159/000184066.

引用本文的文献

1

Assessment of nephrotoxicity.肾毒性评估。

Br J Clin Pharmacol. 1982 Mar;13(3):303-11. doi: 10.1111/j.1365-2125.1982.tb01379.x.

2

Assessment of renal concentrating ability.肾浓缩能力评估。

Br Med J. 1979 Mar 31;1(6167):888-9. doi: 10.1136/bmj.1.6167.888-d.

本文引用的文献

1

Osmolar renal concentrating ability in healthy young men and hospitalized patients without renal disease.健康年轻男性和无肾脏疾病住院患者的肾脏渗透浓缩能力。

N Engl J Med. 1960 Jun 30;262:1306-9. doi: 10.1056/NEJM196006302622603.

2

Urine concentration after fluid deprivation or pitressin tannate in oil.禁水或油剂鞣酸加压素后的尿浓缩功能。

Br Med J. 1956 Feb 4;1(4961):271-4. doi: 10.1136/bmj.1.4961.271.

3

DDAVP test for estimation of renal concentrating capacity in infants and children.用于评估婴幼儿肾脏浓缩功能的去氨加压素试验。

Arch Dis Child. 1974 Aug;49(8):654-9. doi: 10.1136/adc.49.8.654.

4

Urinary concentration test with desmopressin.去氨加压素的尿浓缩试验。

Br Med J. 1978 Mar 25;1(6115):757-8. doi: 10.1136/bmj.1.6115.757.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。